Mortality and its determinants among patients infected with HIV-1 on antiretroviral therapy in a referral centre in Yaounde, Cameroon: A retrospective cohort study

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Poka Mayap, Virginie ^a   Pefura Yone, Eric Walter ^a,b   Kengne, André Pascal ^c   Kuaban, Christopher ^a,d  

^a Yaounde Jamot Hospital   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d UNIVERSITY OF BAMENDA   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; ZIDOVUDINE;

ADULT; ARTICLE; CAMEROON; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TUBERCULOSIS;

EID: 84880629303     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003210     Document Type: Article

References (19)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic. 2012. http://www.unaids.org/en/media/unaids/contentassets/ documents/epidemiology/2012/gr2012/20121120-UNAIDS-Global-Report-2012-en.pdf (accessed 6 May 2013).
2. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006;367:817-24.
3. Palella FJ, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34. (Pubitemid 44306484)
4. Marazzi MC, Liotta G, Germano P, et al. Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Res Hum Retroviruses 2008;24:555-60. (Pubitemid 351571039)
5. Kouanda S, Meda IB, Nikiema L, et al. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study. AIDS Care 2012;24:478-90.
6. Gupta A, Nadkarni G, Yang WT, et al. Early mortality in adults initiating antiretroviral therapy (ART) in low-and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS ONE 2011;6:e28691.
7. Fregonese F, Collins IJ, Jourdain G, et al. Predictors of 5-years mortality in HIV-infected adults starting highly active antiretroviral therapy (HAART) in Thailand. J Acquir Immune Defic Syndr 2012;60:91-8.
8. Laurent C, Meilo H, Guiard-Schmid JB, et al. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative. Clin Infect Dis 2005;41:108-11. (Pubitemid 40863752)
9. Ministère de la Santé Publique. Rapport national de suivi de la déclaration politique sur le VIH/SIDACameroun. 2012.
10. Sieleunou I, Souleymanou M, Schonenberger AM, et al. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health 2009;14:36-43.
11. Pefura Yone EW, Betyoumin AF, Kengne AP, et al. First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study. AIDS Res Ther 2011;8:33.
12. Pefura Yone EW, Soh E, Kengne AP, et al. Non-adherence to antiretroviral therapy in Yaounde: prevalence, determinants and the concordance of two screening criteria. J Infect Public Health 2013;6:307-15.
13. Ministère de la Santé Publique du Cameroun. Directives nationales de prise en charge par les antirétroviraux des personnes (adultes et adolescents) infectés par le VIH. Yaoundé. 2007.
14. Wools-Kaloustian K, Kimaiyo S, Diero L, et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 2006;20:41-8. (Pubitemid 41818113)
15. Biadgilign S, Reda AA, Digaffe T. Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther 2012;9:15.
16. Amuron B, Levin J, Birunghi J, et al. Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study. AIDS Res Ther 2011;8:39.
17. Ministry of Public Health, Republic of Cameroon. National AIDS Control Committee: Towards universal access to care and treatment for adults and children living with HIV/AIDS in Cameroon. Progress Report No 4. 2006.
18. MacPherson P, Moshabela M, Martinson N, et al. Mortality and loss to follow-up among HAART initiators in rural South Africa. Trans R Soc Trop Med Hyg 2009;103:588-93.
19. Yu JK, Chen SC, Wang KY, et al. True outcomes for patients on antiretroviral therapy who are 'lost to follow-up' in Malawi. Bull World Health Organ 2007;85:550-4. (Pubitemid 47041634)